Sucraid

Product manufactured by Qol Medical, Llc

Application Nr Approved Date Route Status External Links
BLA020772 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Sucraid ® (Sacrosidase) Oral Solution Is Indicated As Oral Replacement Therapy Of The Genetically Determined Sucrase Deficiency, Which Is Part Of Congenital Sucrase-Isomaltase Deficiency (Csid).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sacrosidase

Comments